Found 0 matching trials
Mediastinal Lymph Node Dissection Versus Spared Mediastinal Lymph Node Dissection in Stage I GGN NSCLC NA Lung cancer is the leading cause of cancer related death worldwide. Lobecto...
Show More Location
Ethics review board of Tianjin Medical University Cancer Institute and Hospital
Learn More & Join Trial
The Predictive Value of Complement C3 in Patients With Advanced Gastric Cancer N/A This study is designed to investigate whether complement C3 depletion is as...
Show More Location
The First Affiliated Hospital of Sun Yat-sen University
Learn More & Join Trial
Treatment Strategy for Stage IV Gastric Cancer with Positive Peritoneal Cytology As the Only Non-curable Factor NA Gastric cancer with positive is defined as stage IV disease in 7th AJCC/UIC...
Show More Location
Gastrointestinal Cancer Center, Peking University Cancer Hospital
Learn More & Join Trial
Consolidative Local Therapy (CLT) in Oligo-metastatic Urothelial Carcinoma PHASE2 This study investigates the therapeutic benefit of consolidative local ther...
Show More Learn More & Join Trial
Surgery to Remove the Sentinel Lymph Node and Axillary Lymph Nodes After Chemotherapy in Treating Women With Stage II, Stage IIIA, or Stage IIIB Breast Cancer PHASE2 RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Show More Location
University of South Alabama Mitchell Cancer Institute
Learn More & Join Trial
TAD in Primary Breast Cancer With Initially โฅ 3 Suspicious Lymph Nodes N/A Due to high pathological complete remission (pCR) rates in both breast and ...
Show More Location
Kliniken Essen-Mitte (KEM)
Learn More & Join Trial
Magseed and Magtrace Localization for Breast Cancer N/A The aim of this study is to compare the efficacy of the Sentimag localizati...
Show More Location
University Hospital Ostrava
Learn More & Join Trial
Radiotherapy + Chemoimmunotherapy Followed by Surgery in Patients With Limited Metastatic Gastric or GEJ Cancer PHASE2 The goal of this clinical trial is to evaluate the efficacy and safety of r...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
CONVERT-HB1: Radical Prostatectomy After Systemic Therapy for High-volume Metastatic Hormone-sensitive Prostate Cancer PHASE2 This is a prospective, randomized, open-label, phase II multicenter clinica...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Interferon Alfa With or Without Combination Chemotherapy Plus Interleukin-2 in Treating Patients With Melanoma PHASE3 RATIONALE: Interferon alfa may interfere with the growth of cancer cells. I...
Show More Location
University of Texas - MD Anderson Cancer Center
Learn More & Join Trial